Literature DB >> 10607353

The risk of progression to invasive disease.

R G Glogau1.   

Abstract

BACKGROUND: Actinic keratoses occasionally progress to invasive skin cancer. The clinician-dermatologist ideally would like to know which lesions are at individual risk. Various investigators have attempted to answer this problem through a variety of clinical research applications including counting individual lesions in populations at risk, in the general population, and by examining insurance claims data and extrapolating incidence figures.
OBJECTIVE: The purpose of the study was to ascertain the range of risks for progression of actinic keratoses to invasive skin cancer.
RESULTS: Five clinical research studies were reviewed that covered a period from 1988 to 1998. Published risk of progression of actinic keratoses to invasive squamous cell carcinoma for individual lesions ranged from 0.025% to 16% per year. Extrapolation from these clinical studies suggests a rate of risk of progression of actinic keratoses to invasive squamous cell carcinoma of approximately 8% taken as an average among the cited statistical rates in the studies reviewed.
CONCLUSION: Although the rate of progression of actinic keratoses to invasive squamous cell carcinoma statistically occurs at a low percentage rate ( approximately 10%), the problem for the clinician is that the risk over a broad population does not aid in determining the risk factor for the individual lesion. Hence the decision to treat is made on related clinical factors such as history of persistence, age of patient, discomfort, extent of coexisting photodamage, tolerance for morbidity of therapy, and history of skin cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10607353     DOI: 10.1067/mjd.2000.103339

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  65 in total

1.  Actinic keratoses: a comprehensive update.

Authors:  Sherrif F Ibrahim; Marc D Brown
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

2.  Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

3.  Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation.

Authors:  Christopher Nelson; Darrell Rigel
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

4.  Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.

Authors:  Abel Torres; Leslie Storey; Makala Anders; Richard L Miller; Barbara J Bulbulian; Jizhong Jin; Shalini Raghavan; James Lee; Herbert B Slade; Woubalem Birmachu
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

5.  A case of metastatic squamous cell carcinoma arising from actinic cheilitis.

Authors:  Na Hyun Kwon; Si Yong Kim; Gyong Moon Kim
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

6.  Photoageing skin of the elderly.

Authors:  Sb Khoo
Journal:  Malays Fam Physician       Date:  2010-04-30

7.  The keratin-14 expression in actinic keratosis and squamous cell carcinoma: is this a prognostic factor for tumor progression?

Authors:  Kwang Hyun Choi; Gyong Moon Kim; Si Yong Kim
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

8.  [Histology of malignant tumors caused by UV light].

Authors:  M Megahed
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

Review 9.  [New developments in photodynamic therapy].

Authors:  E Kohl; S Karrer
Journal:  Hautarzt       Date:  2013-05       Impact factor: 0.751

10.  Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.

Authors:  Romain Neugebauer; Katherine A Su; Zheng Zhu; Monica Sokil; Mary-Margaret Chren; Gary D Friedman; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2018-11-17       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.